Fludeoxyglucose F18 · FLUDEOXYGLUCOSE F-18 300 mCi/mL · Injection · Intravenous · 3D Imaging Drug Design and Development LLC
NDC 76451-0118-10 · 10 mL in 1 VIAL, GLASS · ANDA · View full market →
7 companies supply this market — a reasonable cushion if one runs into trouble. One of its named manufacturing plants, 3D Imaging Drug Design and Development, failed FDA inspectionwithin the last two years — the agency’s most serious outcome.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Not scored — fragility is computed for NADAC-priced NDCs.
Establishments this product's FDA label declares, located via FDA registration data. How we built this →
There's no legal definition — it meets 1 of 6 public criteria. Why that matters →
No FDA shortage reports for this drug or its presentations.
No enforcement reports list this package NDC.
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| 3D Imaging Drug Design and Development LLC | FLUDEOXYGLUCOSE F-18 300 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
| Kreitchman PET Center | FLUDEOXYGLUCOSE F-18 100 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
| MIPS Cyclotron & Radiochemistry Facility | FLUDEOXYGLUCOSE F-18 300 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
| The Feinstein Institute For Medical Research | FLUDEOXYGLUCOSE F-18 400 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
| The Regents of the University of Michigan | FLUDEOXYGLUCOSE F-18 300 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
| The University of Texas MD Anderson Cancer Center | FLUDEOXYGLUCOSE F-18 300 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
| UCSF Radiopharmaceutical Facility | FLUDEOXYGLUCOSE F-18 300 mCi/mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
DrugDashboards, "Fludeoxyglucose F18 — NDC 76451-0118-10," retrieved September 3, 2026, https://drugdashboards.com/drug/76451011810.
Free to cite with attribution — see how the data is put together.